BR112014030992A2 - composições compreendendo calcogenetos e métodos relacionados - Google Patents

composições compreendendo calcogenetos e métodos relacionados

Info

Publication number
BR112014030992A2
BR112014030992A2 BR112014030992A BR112014030992A BR112014030992A2 BR 112014030992 A2 BR112014030992 A2 BR 112014030992A2 BR 112014030992 A BR112014030992 A BR 112014030992A BR 112014030992 A BR112014030992 A BR 112014030992A BR 112014030992 A2 BR112014030992 A2 BR 112014030992A2
Authority
BR
Brazil
Prior art keywords
calcogenides
compositions
related methods
reduced form
methods
Prior art date
Application number
BR112014030992A
Other languages
English (en)
Inventor
Iwata Akiko
B Roth Mark
l morrison Michael
Original Assignee
Hutchinson Fred Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hutchinson Fred Cancer Res filed Critical Hutchinson Fred Cancer Res
Publication of BR112014030992A2 publication Critical patent/BR112014030992A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • C01B17/24—Preparation by reduction
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • C01B17/32—Hydrosulfides of sodium or potassium
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/007—Tellurides or selenides of metals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/04—Binary compounds including binary selenium-tellurium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/08—Tubes; Storage means specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes

Abstract

resumo: "composições compreendendo calcogenetos e métodos relacionados" a presente invenção refere-se a composições compreendendo calcogenetos numa forma reduzida, a métodos relacionados de produção de composições compreendendo calcogenetos numa forma reduzida, a dispositivos para liberar uma forma reduzida de um composto a um indivíduo, bem como a métodos para o tratamento ou prevenção de lesões ou doenças que utilizam uma composição compreendendo um calcogeneto numa forma reduzida.
BR112014030992A 2012-06-13 2013-06-12 composições compreendendo calcogenetos e métodos relacionados BR112014030992A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261659311P 2012-06-13 2012-06-13
US201361798043P 2013-03-15 2013-03-15
PCT/US2013/045395 WO2013188528A1 (en) 2012-06-13 2013-06-12 Compositions comprising chalcogenides and related methods

Publications (1)

Publication Number Publication Date
BR112014030992A2 true BR112014030992A2 (pt) 2017-06-27

Family

ID=49758688

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014030992A BR112014030992A2 (pt) 2012-06-13 2013-06-12 composições compreendendo calcogenetos e métodos relacionados

Country Status (13)

Country Link
US (1) US20150290240A1 (pt)
EP (1) EP2861718A4 (pt)
JP (1) JP2015527975A (pt)
KR (1) KR20150021509A (pt)
CN (1) CN104471058A (pt)
AU (1) AU2013274325A1 (pt)
BR (1) BR112014030992A2 (pt)
CA (1) CA2875212A1 (pt)
HK (1) HK1209782A1 (pt)
IN (1) IN2014MN02391A (pt)
MX (1) MX2014014524A (pt)
RU (1) RU2015100257A (pt)
WO (1) WO2013188528A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6573620B2 (ja) * 2014-02-10 2019-09-11 フレッド ハッチンソン キャンサー リサーチ センター 心臓発作及び虚血損傷のハロゲン治療
CN109650353A (zh) * 2019-01-14 2019-04-19 成都中建材光电材料有限公司 一种高纯二硫化硒的制备方法
WO2021261941A1 (ko) * 2020-06-25 2021-12-30 한양대학교 에리카산학협력단 기능화된 전이금속 디칼코게나이드를 포함하는 패혈증 예방 또는 치료용 약학적 조성물
CN114471430B (zh) * 2022-02-07 2024-01-02 天津大学 一种连续生产碱金属硫化物的装置及其合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499852A (en) * 1975-03-04 1978-02-01 Smith & Nephew Pharma Packaging
US5208336A (en) * 1990-10-19 1993-05-04 Sterling Drug Inc. Selenomerocyanines and processes for preparation and methods of use and compositions thereof
US5616214A (en) * 1995-09-12 1997-04-01 Pulp And Paper Research Institute Of Canada Determination of sodium sulfide and sulfidity in green liquors and smelt solutions
PE20001435A1 (es) * 1998-11-16 2000-12-14 Paques Bio Syst Bv Proceso para la produccion de sulfuro de hidrogeno a partir de azufre en su condicion elemental y uso del mismo en la recuperacion de metales pesados
US6579705B2 (en) * 2001-04-04 2003-06-17 Consortium Fur Elektrochemische Industrie Gmbh Process for preparing non-proteinogenic L-amino acids
KR100906949B1 (ko) * 2002-02-26 2009-07-08 가부시키가이샤 구라레 수지 조성물 및 다층 구조체
CA2566158A1 (en) * 2004-05-14 2005-11-24 Abbott Laboratories Kinase inhibitors as therapeutic agents
WO2007124447A2 (en) * 2006-04-20 2007-11-01 Fred Hutchinson Cancer Research Center Use of chalcogenides for treating shock and other adverse conditions
JP5303465B2 (ja) * 2006-10-05 2013-10-02 イカリア， インコーポレイテッド 液体カルコゲナイド組成物ならびにそれを製造および使用する方法
JP5083753B2 (ja) * 2007-02-26 2012-11-28 独立行政法人理化学研究所 ４，５−ジメチル−［１，３］ジセレノール−２−セロンの新規製造方法
JP4028588B2 (ja) * 2007-04-27 2007-12-26 政弘 井筒 リグノセルロース系バイオマスの利用方法
EP2564857B1 (en) * 2008-03-06 2017-05-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents

Also Published As

Publication number Publication date
IN2014MN02391A (pt) 2015-08-21
WO2013188528A1 (en) 2013-12-19
CA2875212A1 (en) 2013-12-19
MX2014014524A (es) 2015-02-24
CN104471058A (zh) 2015-03-25
KR20150021509A (ko) 2015-03-02
AU2013274325A1 (en) 2014-12-11
RU2015100257A (ru) 2016-08-10
JP2015527975A (ja) 2015-09-24
EP2861718A4 (en) 2016-03-23
US20150290240A1 (en) 2015-10-15
HK1209782A1 (en) 2016-04-08
EP2861718A1 (en) 2015-04-22

Similar Documents

Publication Publication Date Title
EA201290919A1 (ru) Индазольные соединения и их применение
CR20140397A (es) Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks
ECSP14013329A (es) Compuestos de arylcarbonil-4-oxy-piperidina utilizados para el tratamiento de enfermedades neurodegenerativas
CU20140025A7 (es) Pirimidinas anilladas sustituidas
BR112012030699A2 (pt) métodos para tratar câncer de bexiga
UY34701A (es) Formas sólidas de un profármaco de nucleótidos de tiofosforamidato
NI201400043A (es) 4 - fenil - piridinas sustituidas para el tratamiento de enfermedades relacionadas con el receptor de nk1
DOP2013000239A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso.
BR112015022047A2 (pt) métodos para tratar câncer de bexiga
PE20210949A1 (es) Anticuerpos anti-fgfr2iiib afucosilados
NI201500140A (es) Compuestos y composiciones terapéuticos
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
CO6741218A2 (es) Composición pesticida y procesos relacionados con el mismo
CR20140342A (es) Composiciones y métodos para el tratamiento de enfermedades y trastornos hepáticos
BR112014014939A2 (pt) composição de tratamento de sementes
GT201400242A (es) "nuevos compuestos de pirazol"
BR112015003957A2 (pt) alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria
EA201690191A1 (ru) Фармацевтическая композиция для замедленного высвобождения ланреотида
ECSP14027694A (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido
PE20151669A1 (es) Compuestos de azetidiniloxifenilpirrolidina
BR112014030992A2 (pt) composições compreendendo calcogenetos e métodos relacionados
BR112014005839A2 (pt) composições e métodos para tratamento do câncer usando inibidor da pi3k? e inibidor do caminho da mapk, incluindo inibidores da mek e da raf
NZ707773A (en) Methods of treating liver diseases

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]